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ABSTRACT: Antimicrobial peptides (AMPs) are a potential source of new molecules to counter the increase in 
antimicrobial resistant infections but a better understanding of their properties is required to understand their native function 
and for effective translation as therapeutics. Details of the mechanism of their interaction with the bacterial plasma 
membrane are desired since damage or penetration of this structure is considered essential for AMP activity. Relatively 
modest modifications to AMP primary sequence can induce substantial changes in potency and/or spectrum of activity but, 
hitherto, have not been predicted to substantially alter the mechanism of interaction with the bacterial plasma membrane. 
Here we use a combination of molecular dynamics simulations, circular dichroism, solid-state NMR and patch clamp to 
investigate the extent to which temporin B and its analogues can be distinguished both in vitro and in silico on the basis of 
their interactions with model membranes. Enhancing the hydrophobicity of the N-terminus and cationicity of the C-terminus 
in temporin B improves its membrane activity and potency against both Gram-negative and Gram-positive bacteria. In 
contrast, enhancing the cationicity of the N-terminus abrogates its ability to trigger channel conductance and renders it 
ineffective against Staphylococcus aureus while nevertheless enhancing its potency against Escherichia coli. Our findings 
suggest even closely related AMPs may target the same bacterium with fundamentally differing mechanisms of action.  
Introduction 
Antimicrobial peptides (AMPs) are a possible new source of antibiotic molecules and attract interest due to their multifaceted 
features which confer a broad spectrum of activity and low rate of resistance development.1-3 AMPs have been isolated from almost 
all living forms, from bacteria to humans, where they act as a primary line of defence against pathogenic infections.4-6 Often, a 
family of AMPs are found in each organism, sharing substantial primary sequence similarity and/or physical properties. It is 
generally accepted that the main factor determining the potency of AMPs is their interaction with the bacterial plasma membrane 
and that they kill pathogens by altering the permeation of the membrane and causing cell lysis1-3, 7 or by crossing the membrane to 
interact with intracellular targets.1,6,8 Damage of model membranes by AMPs is well documented, with alteration of membrane 
permeability by AMPs explained using a variety of hypothetical models which have been added to and/or refined in recent years.1,7 
It has been assumed that AMPs that are closely related will interact with bacterial plasma membranes with broadly similar 
mechanisms. 
The most common approach adopted to improve the antimicrobial properties of native AMPs, involves the modification of the 
physicochemical properties of the peptide sequence, including the net positive charge, hydrophobicity, hydrophobic moment and 
potential to adopt helical conformation to balance antimicrobial activity and host cell toxicity.9 Such studies often proceed on the 
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basis that the overall mechanisms of bactericidal action are not expected to alter following minor sequence modification but that 
the native function of the AMP is enhanced. Recently we have compared the mechanism of action of seemingly closely related 
AMPs from the same class and found substantial differences in both the bacterial response to challenge and the ability of each 
peptide to penetrate model membranes.10,11 As a result, we hypothesised that even relatively minor alterations to the primary 
sequence of an AMP can result in fundamentally different behaviour when binding to models of the bacterial plasma membrane. 
The effects of an altered mechanism of action may be neutral but could lead to substantial changes in anti-bacterial potency and/or 
selectivity and may afford distinct native functions to even closely related AMPs from the same family. 
To test our hypothesis, we report here our investigation of the effect of previously reported modifications to the sequence of 
temporin B on its ability to insert and disrupt model membranes and the effect this has on bactericidal activity against 
representatives of Gram-negative and Gram-positive pathogens. Temporin B (TB) belongs to the temporin family, one of the largest 
families of AMPs, whose members are closely related and were initially isolated from the skin mucus of the European common 
frog Rana temporaria.12-14 Temporins are mainly active against Gram-positive bacteria, with minimal inhibitory concentration 
(MIC) values ranging from 2.5-20 µM.13,14 They are less active against Gram-negative bacteria, with the exception of temporin L, 
which showed MIC ranging from 2-20 µM.13,15 Temporin B L1FK and temporin B KKG6A are two analogues derived from the 
temporin B sequence, designed to improve activity against Gram-negative bacteria. Temporin B L1FK was obtained from a 
computational statistical model designed to predict the toxicity of the peptide as well as the antimicrobial activity. Temporin B 
L1FK maintains the physicochemical properties of the native peptide, such as hydrophobicity and amphipathic profile, but it has a 
broader spectrum of activity at low concentration, including against Gram-negative bacteria, as well as a higher potency in 
eradication of biofilms.16,17 Temporin B KKG6A was instead obtained by further optimization of an analogue obtained through 
alanine scanning of the temporin B sequence. The properties of temporin B KKG6A differ from temporin B, with a higher positive 
charge, a different amphipathic profile and a higher helical content, but is reported to have improved antimicrobial activity against 
Gram-negative and Gram-positive bacteria, a low haemolytic activity and a strong tendency to bind to lipopolysaccharide.16,18  
To distinguish between the mode of interaction of the three temporin B analogues we combined both time-resolved and steady-
state biophysical methods including all atom molecular dynamics simulations (using NMR structures of the three temporin B 
peptides solved in anionic detergent as a starting point), with circular dichroism and solid-state NMR to determine conformational 
and topological differences during the initial stages of membrane interaction and in the steady state. In addition, electrophysiology 
measurements of the current transitions on model membranes obtained with the patch-clamp technique reveal how these impact on 
the ability of each peptide to permeate analogous model membranes and enable understanding of the antibacterial outcome. 
Experimental procedures 
Materials. Peptides (Table 1) were purchased from Pepceuticals (Enderby, UK) and Cambridge Research Biochemicals (Cleveland, 
UK) as desalted grade and were further purified using water/acetonitrile gradients using a Waters SymmetryPrep C8, 7 mm, 19 × 
300 mm column. They were all amidated at the C-terminus. The lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-
glycerol) (POPG), 1-palmitoyld31-2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (POPG-d31), 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphoethanolamine (POPE), 1-palmitoyld31-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE-d31), 1,2-diphytanoyl-sn-
glycero-3-phospho-(1'-rac-glycerol) (DPhPG) and 1,2-diphytanoyl-sn-glycero-3-phosphoethanolamine (DPhPE) were purchased 
from Avanti Polar Lipids, Inc. (Alabaster, AL) and used without any purification. All other reagents were used as analytical grade 
or better. 
Antibacterial activity assay. The antibacterial activity of the peptides studied was assessed through a modified two-fold broth 
microdilution assay, as described before.10 Briefly, a two-fold dilution of peptide stock solutions was performed in either non-
cation adjusted Müller-Hinton broth (MHB) or Tryptic Soy broth (TSB) in a 96-well polypropylene microtiter plate. Then, 100 µl 
of bacterial suspension (back diluted from overnight cultures to an A600 of 0.01) were added to 100 µl of peptide solution in each 
well of the plate. Growth and sterility controls were present for each experiment. The plate was incubated at 37°C for 18 hours 
without shaking and the MIC was defined as the lowest concentration where no visible growth could be detected by measuring the 
absorbance (A600) on an Omega plate reader. 
NMR spectroscopy and structure determination. Liquid state NMR spectroscopy experiments and data analysis were performed as 
described before.11 The samples solution consisted of 2 mM peptide and 100 mM deuterated sodium dodecyl sulphate (SDS-d25) 
micelles. 10% D2O containing trimethylsilyl propanoic acid (TSP) was added for the lock signal and as internal chemical shift 
reference. NMR spectra were acquired on a Bruker Avance 500 MHz spectrometer (Bruker, Coventry, UK) equipped with a 
cryoprobe. Standard Bruker TOCSY and NOESY pulse sequences were used, with water suppression using an excitation sculping 
sequence with gradients (mlevesgpph and noesyesgpph). The 1H 90-degree pulse length was 8.0s. One TOCSY with a mixing time 
of 60 ms, and two NOESY with mixing time of 100 and 200 ms were acquired for each sample. The relaxation delay was 1 s. 2048 
data points were recorded in the direct dimension, and either 256 or 512 data points in the indirect dimension. CARA (version 
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1.9.1.2) and Dynamo software19,20 were used for the structure calculation. Inter-proton NOEs interactions were used as distance 
restraints in the structure calculation. CARA software generated a total of 200 structures on UNIO’08 (version 1.0.4)21 and XPLOR-
NIH (version 2.40),22,23 after 7 iterations, using the software’s simulated annealing protocol. 20 structures with the lowest energy 
were chosen to produce a final average structure. In the case of ambiguous NOEs assignments by CARA software, Dynamo 
software’s annealing protocol was applied. Only unambiguous NOEs were used in this case after being classified as strong, medium 
and weak on the base of the relative intensity of the cross-peaks in the NOESY spectra. On the base of this classification an upper 
limit of 0.27, 0.33 and 0.50 nm have been applied, respectively, as restraint on the corresponding inter-proton distance, as described 
previously.24 One thousand structures were calculated and the 100 conformers with the lowest potential energy were selected for 
the analysis. The selected 100 conformers were aligned, and the root mean square deviation (RMSD) of the backbone heavy atoms 
was calculate with respect to their average structure. The conformer with the lowest RMSD was chosen as the starting structure for 
the MD simulations (see below). Solvent molecules were not included in the calculations. Structural coordinates and chemical shift 
tables were deposited in the Protein Data Bank (PDB; www.rcsb.org) and Biological Magnetic Resonance Bank (BMRB; 
www.bmrb.wisc.edu) respectively under accession codes 6GIL, 6GIK and 6GIJ (PDB) and 34274, 34273 and 34272 (BMRB) for 
temporin B, temporin B L1FK and temporin B KKG6A respectively. Details of structural validation can be found in the PDB.   
Molecular dynamic simulations. Simulations were carried out on either a Dell Precision quad core T3400 or T3500 workstation 
with a 1 kW Power supply (PSU) and two NVIDA PNY GeForce GTX570 or GTX580 graphics cards using Gromacs.25 The 
CHARMM36 all-atom force field was used in all simulations.26,27 The initial bilayer configuration was built using CHARMM-
GUI.28 All membranes in this project contained a total of 512 lipids, composed either of POPE/POPG (75:25 mol:mol) or POPG 
to reflect the lipid charge ratios of the plasma membrane of Gram-negative and Gram-positive bacteria, respectively. Eight peptides 
were inserted at least 30 Angstrom above the lipid bilayer in a random position and orientation at least 20 Angstrom apart. The 
starting structures were copies of the same conformer obtained from the NMR calculation in SDS micelles. The system was solvated 
with TIP3P water and Na+ ions added to neutralize. Energy minimization was carried out at 310 K with the Nose-Hoover thermostat 
using the steepest descent algorithm until the maximum force was less than 1000.0 kJ/ml/nm (~3000-4000 steps). Equilibration 
was carried out using the NVT ensemble for 100 ps and then the NPT ensemble for 1000 ps with position restraints on the peptides. 
Hydrogen bond angles were constrained with the Lincs algorithm. Final simulations were run in the NPT ensemble using 2 
femtosecond intervals, with trajectories recorded every 2 picoseconds. All simulations were run for a total of 100 nanoseconds and 
repeated twice, with peptides inserted at different positions and orientations, giving a total of approximately 1.2 ms simulation. 
Liposomes preparation. Small unilamellar vesicles (SUVs) and multi-lamellar vesicles (MLVs) were prepared for circular 
dichroism (CD) and solid-state NMR (ssNMR) spectroscopy, respectively, and prepared as previously described.11 In both cases, 
lipids powders were solubilized in chloroform and dried under rotor-evaporation. To completely remove the organic solvent, the 
lipid films were left overnight under vacuum and hydrate in 5 mM Tris buffer with or without the addition of 100 mM NaCl (pH 
7.0). Lipid suspension was subjected to 5 rapid freeze-thaw cycles for further sample homogenisation.  
For ssNMR POPE/POPG-d31 (75:25, mol:mol), POPE/POPE-d31/POPG (50:25:25, mol:mol) and POPG/POPG-d31 (75:25, 
mol:mol) were used to prepare the vesicles. MLVs obtained were centrifuged at 21000 g for 30 minutes at room temperature and 
then pellets were transferred to Bruker 4 mm rotors for NMR measurements. Peptides were added to the buffer at a final 
concentration of 2% by mol, relative to lipids. POPE/POPG (75:25, mol:mol) and POPG SUVs were obtained by sonicating the 
lipid suspension on Soniprep 150 (Measuring and Scientific Equipment, London, UK) for 3 × 7 minutes with amplitude of 6 
microns in the presence of ice to avoid lipid degradation. The SUVs were stored at 4C∘ and used within 5 days from preparation. 
Circular dichroism spectroscopy. Far-UV spectra of the peptides in the presence of SUVs and SDS micelles were acquired on a 
Chirascan Plus spectrometer (Applied Photophysics, Leatherhead, UK). Liposome samples were maintained at 310 K. Spectra were 
recorded from 260 to 190 nm. Lipid suspension was added to a 0.5 mm cuvette at a final concentration of 5.0 mM and then a few 
μl of a concentrated peptide solution were added and thoroughly mixed to give the indicated final peptide-to-lipid molar ratios. The 
same experimental conditions were used to investigate peptides secondary structure in SDS micelles. Final peptide concentration 
in the 0.5 mm cuvette was 40 µM, while SDS micelles concentration was 2 mM (L/P=50). In processing, a spectrum of the peptide 
free suspension was subtracted and Savitsky-Golay smoothing with a convolution width of 5 points applied. 
Solid state 2H-NMR. 2H quadrupole echo experiments29 were performed at 61.46 MHz on a Bruker Avance 400 NMR spectrometer 
using a 4 mm MAS probe, spectral width of 100 KHz and with recycle delay, echo delay, acquisition time and 90° pulse lengths 
of 0.25 s, 100 μs, 2.6 ms and 3 μs respectively. The temperature was maintained at 310 K to keep the bilayers in their liquid-
crystalline phase. During processing the first 10 points were removed in order to start Fourier-transformation at the beginning of 
the echo. Spectra were zero filled to 1 k points and 50 Hz exponential line-broadening was applied. Smoothed deuterium order 
parameter profiles were obtained from symmetrised and dePaked 2H-NMR powder spectra of POPG-d31 using published 
procedures.30-32 
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Electrophysiology experiments (Patch-clamp). Giant unilamellar vesicles (GUVs) composed of DPhPE/DPhPG (60:40, mol:mol) 
and DPhPG were prepared in the presence of 1 M sorbitol by electroformation method in an indium-tin oxide (ITO) coated glass 
chamber connected to the Nanion Vesicle Prep Pro setup (Nanion Technologies GmbH, Munich, Germany) using a 3-V peak-to-
peak AC voltage at a frequency of 5 Hz for 120 and 140 minutes, respectively, at 36°C.33-35 Bilayers were formed by adding the 
GUVs solution to a buffer containing 250 mM KCl, 50 mM MgCl2 and 10 mM HEPES (pH 7.00) onto an aperture in a borosilicate 
chip (Port-a-Patch®; Nanion Technologies) and applying 70-90 mbar negative pressure resulting in a solvent-free membrane with 
a resistance in the GΩ range. After formation, a small amount of peptide stock solution (in water) was added to 50 µL of buffer 
solution in order to obtain its active concentration. All the experiments were carried on with a positive holding potential of 50 mV. 
The active concentration, the concentration at which the peptide first showed membrane activity, for each peptide was obtained 
through a titration performed in the same conditions. For all the experiments a minimum of 6 according repeats was done. Current 
traces were recorded at a sampling rate of 50 kHz using an EPC-10 amplifier from HEKA Elektronik (Lambrecht, Germany). The 
system was computer controlled by the PatchControl™ software (Nanion) and GePulse (Michael Pusch, Genoa, Italy, 
http://www.ge.cnr.it/ICB/conti_moran_pusch/programs-pusch/software-mik.htm). The data were filtered using the built-in Bessel 
filter of the EPC-10 at a cut-off frequency of 10 kHz. The experiments were performed at room temperature. Data analysis was 
performed with the pClamp 10 software package (Axon Instruments). 
Results 
Primary sequence and antibacterial activity. Comparison of the primary sequences of temporin B (TB) and its two analogues, 
temporin B L1FK and temporin B KKG6A indicates the extent of the modifications to the primary sequence and their effects on 
nominal charge, hydrophobicity (H) and hydrophobic moment (µH), assuming each peptide adopts an idealised α-helix (Table 1). 
All three temporin B peptides are relatively hydrophobic and short and even single amino acid substitutions will be expected to 
have some impact on the physicochemical properties. Temporin B L1FK and temporin B KKG6A were both designed16,18 to 
enhance the activity of temporin B. For temporin B L1FK, the optimization involved the substitution of Leu1 with Phe1 to render 
the N-terminus more hydrophobic, the addition of a lysine residue at the C-terminus and the deletion of Asn7.16 Compared with 
the parent peptide, these modifications led to an increase in potency, albeit modest for Pseudomonas aeruginosa, for all species 
(Table 2). The activity of Temporin B L1FK was greater against both Gram-positive and Gram-negative bacterial isolates and 
against a Candida albicans isolate, and the increased potency to Klebsiella pneumoniae suggests the L1FK temporin B analogue 
can be considered a broader spectrum AMP than its parent peptide. To create temporin B KKG6A, two lysines are added to the N-
terminus, increasing the nominal positive charge, and Gly6 is substituted with alanine.18 These modifications improved the activity 
of the peptide against E. coli NCTC 12923 (a four-fold improvement in potency) and Acinetobacter baumanii in MHB, but the 
peptide loses activity against all Gram-positive isolates. Temporin KKG6A is more potent than its parent peptide but has a narrow 
spectrum of activity. The activity of the three temporin B peptides was modest against Pseudomonas aeruginosa, notably however 
the potency of temporin B KKG6A was greater when susceptibility testing was performed in TSB when compared with MHB. 
While the results reported here for temporin B L1FK are mostly in agreement with those reported previously16, those for temporin 
B KKG6A are in disagreement. Although the enhancement in activity against E. coli is consistent, an up to 8-fold improvement in 
the activity against Gram-positive bacteria16,18 and 16-fold against P. aeruginosa16 was reported for temporin KKG6A when 
compared to temporin B. Temporin B L1FK was also reported previously to have greater potency against P. aeruginosa.16 Different 
protocols were applied in the previous studies, notably the use of TSB for culturing bacteria and challenges performed in sodium-
phosphate buffer16, or culture in TSB or Luria Bertani broth followed by transfer to MHB and a 1.6 fold dilution by distilled water.18 
It has been shown recently that the choice of media can substantially alter the result of antibacterial susceptibility testing36,37 and 
we show here that, while use of TSB often led to higher MICs being reported, in the case of P. aeruginosa PAO1 the potency of 
temporin B KKG6A is increased to the point that an MIC is established whereas in MHB no activity is detectable (Table 2). When 
cultured in TSB, P. aeruginosa PAO1 is susceptible to temporin KKG6A and 50 µM peptide is sufficient, in vitro, to downregulate 
the pro-inflammatory chemokines and cytokines interleukin (IL)-8, IL-1β, IL-6 and TNF-α, produced downstream by P. aeruginosa 
infected human bronchial epithelial cells.38  The ability of either temporin B L1FK or temporin B KKG6A to function in vivo is as 
yet unknown and hence it is yet to be established which in vitro susceptibility testing protocols are predictive of a therapeutic effect 
for this class of AMP. Nevertheless, the present antibacterial susceptibility testing indicates that relatively small changes in the 
primary sequence can have substantial impacts on antimicrobial activity, that the spectrum of activity is altered and, further, that 
these impacts cannot be easily related to changes in physicochemical properties such as nominal charge or hydrophobicity. Distinct 
mechanisms and specific effects related to the peptide conformation or ability to effectively penetrate membranes can be suspected. 
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Figure 1. Three-dimensional structure for the three temporin B analogues. Structures were determined through 1H-NOESY 
NMR spectroscopy in SDS-d25 micelles (peptide/detergent equal to 1/50). The structure with the minimum RMSD is shown and 
was used as starting point in the MD simulations. The hydrophobic and hydrophilic residues are shown in yellow and blue 
respectively for temporin B (A), temporin B L1FK (B) and temporin B KKG6A (C). CD spectra of the AMPs in the same conditions 
used for NMR experiments are shown in (E). NMR and CD spectroscopy both revealed a lower propensity in helical folding for 
TB and TB L1FK peptides. NMR structures were used as starting configurations for MD simulations of model membranes. 
Conformation and structure of temporin B peptides in sodium dodecyl sulphate (SDS) micelles and in model membranes in the 
steady state. As a first step, the secondary structures of the three temporin B peptides were initially analysed and characterised with 
far-UV CD and NMR spectroscopy in the presence of SDS micelles to mimic the negative surface of a bacterial membrane (Fig. 
1; Fig. S1). Structures for temporin B and temporin B KKG6A have been solved previously in LPS micelles18,39 and in the presence 
of E. coli and Staphylococcus epidermidis cells40,41 although coordinates are not available in the Protein Data Bank. Temporin B 
KKG6A adopts a more extended double β-turn (~40% of the whole sequence) in the -IVANLK- region. In all three peptides there 
is little evidence of order from the N-terminus to the glycine residue (temporin B and temporin B L1FK) or from the N-terminus 
to the proline residue (temporin B KKG6A). The structure of temporin B KKG6A is consistent with that described in the presence 
of LPS micelles and E. coli cells where an ordered α-helix extends from Pro5 until the C-terminus with the N-terminus largely 
disordered.18,40 In support, the far-UV CD spectra indicate that the Ramachandran angles adopted by the ordered regions of the 
peptides are similar to those of an α-helix and hence an α-helix like spectrum. The greater magnitude of the temporin B KKG6A 
CD spectrum compared with the temporin B CD spectrum reflects the increase from ~27% to ~40% whole molecule order. In 
contrast, the CD spectrum of temporin L1FK is more compatible with the extended α-helix often found in membrane proteins 
located in membranes as opposed to just water.42 These results are in broad agreement with the predicted effects of the design of 
temporin B L1FK16 where the aim was to largely retain the physicochemical properties of the ancestor peptide. 
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Figure 2. Secondary structure analysis of temporin B peptides from MD simulations in model membranes. Dihedral angles 
(psi) and their circular variance are shown for each residue averaged over 100 ns of simulation and eight peptides in temporin B 
(A/B), temporin B L1FK (C/D) and temporin B KKG6A (E/F) peptides when binding to POPE/POPG (A/C/E) or POPG (B/D/F) 
membranes. 
As more realistic models of the plasma membrane in Gram-negative and Gram-positive bacteria respectively, the conformation of 
the peptides in lipid bilayers, composed of either POPE/POPG (75:25 mol:mol) or POPG only, was investigated in the steady state 
through far-UV CD spectroscopy (Fig. S2). Small amounts of peptide stock solution were added to small unilamellar vesicles 
(SUVs) to decrease the lipid-to-peptide ratio and investigate the effect of peptide concentration on the secondary structure. 
Measurements were performed in the presence of 100 mM NaCl, to maintain as similar environment as possible to those used for 
other experimental procedures. All three peptides adopted a disordered structure when in buffered solution and adopted ordered 
conformations, of the type described for temporin B KKG6A in SDS. The titration indicates that all peptide molecules in solution 
bind to the vesicles. A notable exception in the series is illustrated for temporin B itself in the presence of POPE/POPG (75/25) 
and POPG, with a less pronounced negative 220 nm feature which indicates a more ordered tail or a less ordered β-turn (Fig. 
S2A/D). Otherwise, differences are small and the CD spectra can be said to be broadly similar. 
MD simulations reveal different conformational flexibilities on initial binding to model membranes. To characterise the interaction 
of temporin B analogues with model membranes with atomic resolution, duplicate all atom simulations were run for 100 ns. In 
each case, using the structures determined by NMR in SDS for the starting configuration, eight peptides for each temporin B 
analogue were placed in water above bilayers comprising either 512 POPG lipids or a mixture of 384 POPE and 128 POPG lipids. 
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Figure 3. Temporin B peptide topology during 100 ns MD simulation in model membranes. The depth of temporin B (A/B), 
temporin B L1FK (C/D) and temporin B KKG6A (E/F) insertion is shown as the Z-position relative to the phosphate group for 
each residue averaged over all eight peptides in each simulation. Positive or negative values indicate the peptides are below or 
above the phosphate group, respectively for peptides in POPE/POPG (A/C/E) or POPG (B/D/F). 
Averaged psi dihedral angles for each residue in the eight temporin B peptides are similar in the presence of both POPE/POPG and 
POPG (Fig. 2A/B; Fig. S3A/B) membranes; as in previous work,11 phi dihedral angles were not affected and are not shown. The 
values for these psi dihedral angles do not lie in the range of values accepted for α-helix conformations but instead correspond to 
more extended conformations.43 Temporin B displays considerable conformational flexibility during these first 100 ns which 
increases from N- to C-terminus. Modifications made to generate temporin B L1FK have a noticeable impact on the preferred 
conformation adopted in both membrane types; the deletion of Asn7, such that Leu7 now follows Gly6, induces a shift in local 
conformation with psi angles for residues 6-8 (GLL) consistent with the β-turn (single turn α-helix) conformation (Fig. 2C/D; Fig. 
S3C/D). The conformational flexibility of temporin B is however retained throughout the length of the modified peptide. The 
modifications made to generate temporin B KKG6A have a much more substantial impact. Except for the five residues at the N-
terminus, there is a shift in psi angles associated with the replacement of a glycine (Gly6 in temporin B) with alanine (Ala9 in 
temporin B KKG6A) such that residues 6-12 (PIVANLK) adopt a two turn α-helix conformation (Fig. 2E/F; Fig. S3E/F). 
Conformational flexibility is also reduced throughout the length of the peptide with only the two residues at the C-terminus 
unaffected. 
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Figure 4. Temporin B peptides aggregation during 100 ns MD simulation in model membranes. The probability of temporin 
B (A/B), temporin B L1FK (C/D) and temporin B KKG6A (E/F) aggregation is reported as frequency histogram of the Cα-Cα 
distances, respectively for peptides in POPE/POPG (A/C/E) or POPG (B/D/F) membranes. 
Modification of temporin B affects its penetration of lipid bilayers and aggregation at their surface. In addition to changes in 
preferred secondary structure, MD simulations allow visualisation of the ability of the three temporin B peptides to penetrate either 
POPE/POPG or POPG bilayers (Fig. 3; Fig. S4). All peptides start the simulation in water with no contact with the membrane. 
After the simulation had run for 100 ns all the peptides were interacting with the lipids regardless of the composition of the 
membrane. In general, the temporin B peptides showed deeper insertion in POPG membranes, as observed previously,44 compared 
with POPE/POPG membranes. Contact and insertion began at the N-terminus in all cases as has been observed for other AMPs 
including temporin L, aurein 2.5, cecropin B and and pandinin 2.45,46,47 The temporin B peptides were also frequently self-associated 
(Fig. 4; Fig. S5) and assembled as dimers, trimers or even tetramers (Fig. S6-11). Aggregation was consistently lower in POPG 
membranes compared with POPE/POPG membranes. Temporin B is known to act in synergy with temporin L with the latter acting 
to inhibit the aggregation of the former.48 Acting alone, temporin B struggles to penetrate far into POPE/POPG membranes, with 
residues 1-7 only inserting and these reaching only the interfacial region of the bilayer (Fig. 3A; Fig. S4), with most peptides 
residing in an aggregated state (Fig. 4A; Fig. S6). In POPG membranes the aggregation of temporin B is much less pronounced 
(Fig. 4B) and penetration proceeds more rapidly, is deeper – beginning to enter the hydrophobic core - and more of each peptide 
becomes buried (Fig. 3B; Fig. S7).  
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Figure 5. The effect of temporin B peptides on lipids. Capability of the peptides to cluster anionic lipids in POPE/POPG (75:25 
mol:mol) membranes in silico (A). The POPE/POPG ratio of the lipids within 4Å from the peptides is compared across the three 
peptides where a ratio lower than three indicates the peptide tends to cluster the anionic lipids. Temporin B and temporin B KKG6A 
show a higher clustering effect. AMP disordering effect on lipid membranes in the steady state, as obtained from 2H solid-state 
NMR experiments (B-D). The effect of 2 mol% of each AMP was studied in multilamellar vesicles (MLVs) composed of 
POPE/POPG-d31 (75:25) (B), POPE/POPE-d31/POPG (50:25:25) (C) or POPG/POPG-d31 (75:25) (D) in 5 mM Tris-amine buffer, 
pH 7.00 and 100 mM NaCl.  
Temporin B L1FK behaves similarly to temporin B (Fig. 3C/D; Fig. 4C/D; Fig. S4C/D; Fig. S5C/D). However, its initial binding 
and the insertion were more effective than observed for the parent peptide. Temporin B L1FK inserted almost flat in both lipid 
compositions enabling more of the peptide to be buried (Fig. 3C/D; Fig. S4C/D) and, notably in POPE/POPG, had a much lower 
tendency to self-associate than temporin B (Fig. 4A/C; Fig. S5A/C). Again, in POPG bilayers the tendency to self-associate is 
reduced (Fig. 4D) and penetration into the hydrophobic interior of the membrane is greater than in POPE/POPG bilayers (Fig. 3D; 
Fig S8/9).  
In contrast with temporin B and temporin B L1FK, temporin B KKG6A fails to insert into either bilayer beyond the first two 
residues of the N-terminus (Fig. 3E/F; Fig. S4E/F). The result of additional positive charges at the N-terminus, the greater 
proportion of α-helix conformation and the reduced conformational disorder is that temporin B KKG6A has a much lower tendency 
to form higher order aggregates in either membrane, though may still form dimers and trimers (Fig. S10/11). Penetration mediated 
by the previously hydrophobic N-terminus is halted by interactions between the two lysines and anionic lipid headgroups.  
Peptide effects on membrane order. The relative differences in the ability of the temporin B peptides to penetrate lipid bilayers is 
expected to impact on their ability to disorder, disrupt or permeate membranes. In the MD simulations described above, temporin 
B and temporin B KKG6A had a greater tendency to cluster POPG lipids in mixed membranes (Fig. 5A). This could be related 
either to the greater nominal positive charge of these peptides relative to temporin B (Table 1) or to their inability to penetrate 
easily beyond the interfacial region such that cationic residues remain concentrated at the bilayer surface and induce lateral 
separation of anionic and zwitterionic lipids. The interaction of cationic AMPs with anionic lipids has been demonstrated 
previously, in vitro11,49,50 and in silico11,51,52 to induce disordering of the lipid acyl chain and is associated with antimicrobial 
activity. Here, a good qualitative comparison was observed between the peptide induced membrane disordering obtained 
experimentally, in the steady-state, using 2H solid state NMR (Fig. 5B-D) and from disordering of lipids determined to be within a 
4 Å ring of each peptide in MD simulations (Fig. S12).  
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Figure 6. Membrane activity of the temporin B analogues. Representative current traces and all-points histograms for temporin 
B (A/B), temporin B L1FK (C/D) and temporin B KKG6A (E/F) in DPhPE/DPhPG (A/C/E) or DPhPG (B/D/F) membranes. 
Experiments were acquired with a holding potential of +50 mV and in the presence of 250 mM KCl, 50 mM MgCl2, 10 mM 
HEPES, pH 7.0. Y-axis is scaled accordingly to the different amplitudes for the different peptides. 
In the steady state, the average difference (ΔSCD) between the order parameter in the presence and absence of 2 mol% of each 
temporin B peptide on the POPG-d31 (Fig. 5B) and POPE-d31 (Fig. 5C) component in POPE/POPG membranes and POPG-d31 in 
POPG membranes (Fig. 5D) allows comparison of any differing ability to disorder different components of each membrane (2H 
echo NMR spectra are available in the supplementary material (Fig. S13)). Notably, temporin B L1FK has a significantly (p < 0.05) 
greater disordering effect on the anionic component in mixed membranes than temporin B KKG6A (Fig. 5B) while the latter has a 
greater disordering effect on the zwitterionic POPE when compared with both temporin B and temporin B L1FK (p < 0.05) (Fig. 
5.C). No effect of any of the three peptides can be detected on the order parameter for POPG-d31 in POPG membranes (Fig. 5D) 
though the measured order parameter here is more likely to be reporting on an average of those lipids interacting with the peptides 
and those located in the remaining bulk than in the analogous experiments on mixed POPE/POPG-d31 membranes where a higher 
probability of the labelled anionic lipid associating with cationic AMP is expected.  
Temporin B analogues have drastically different abilities to induce conductance activity in model membranes. The whole-cell 
patch-clamp technique allows the measurements of current transitions on a phospholipid membrane. It has been largely used to 
study conductance and kinetics of membrane channels in cells and in lipid bilayers.53 The recent development of the Port-a-Patch® 
automated patch-clamp system from Nanion Technologies (Munich, Germany), enables rapid testing of membrane active molecules 
with an automated system, bringing this technique into the drug discovery pipeline.54-56 Previous works have applied this technique 
to investigate the mode of action of AMPs.57-64 In particular, the three main membrane-activity models described in the introduction 
can be distinguished.57 This protocol involved the use of a microperfusion system on a standard pipette patch-clamp set up and 
mammalian cells.57 We report here that the same aim was achieved with the Port-a-Patch® system and the use of model membranes, 
which enabled the peptides to be distinguished on the basis of their disruption of either DPhPE:DPhPG (60:40 mol:mol) or DPhPG 
bilayers, mimicking Gram-negative and Gram-positive bacteria, respectively.65-69 Diphytanyl chains are used here since membranes 
composed of these lipids are in a fluid phase at room temperature, irrespective of headgroup. 
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Figure 7. Latency and duration of membrane activity. The average time elapsed between peptide addition and the first 
appearance of membrane activity (A/B) and the average duration of activity before the membrane breaks (C/D) is shown for 
DPhPE/DPhPG (A/C) and DPhPG (B/D) membranes.  
The membrane activity of the peptides can be distinguished on the basis of 1) the concentration required for membrane activity to 
be recorded (Table 1), 2) the latency – the time taken for conductance to begin after addition of peptide, 3) the duration of 
conductance activity, 4) the amplitude and number of each conductance event and 5) whether the AMP ultimately caused the 
membrane to break. The concentration used for the experiments for each peptide is the minimum concentration necessary to observe 
activity and was obtained with a peptide titration of the model membrane (Table 1). Notably there is an apparent relationship 
between the ability of each temporin B peptide to insert rapidly into model membranes, as determined by the MD simulations, and 
the concentration required to induce conductance. Less than half as much temporin B L1FK as temporin B was required to induce 
conductance in DPhPE/DPhPG membranes while approximately seven times more temporin B than temporin B L1FK is required 
to induce conductance in DPhPG membranes. Temporin B KKG6A, for which no more than the two N-terminal residues penetrated 
either POPE/POPG or POPG bilayers, required nearly eighteen and over twenty times as much peptide as temporin B L1FK to 
induce conductance in, respectively, DPhPE/DPhPG and DPhPG membranes.     
Characteristic channel like activity - well-defined events with discrete opening levels – has been observed previously by others for 
alamethicin, gramicidin A, cecropin B and dermicidin58-60 and for other peptides in our hands. However, temporin B presented an 
irregular activity in both mixed and negatively charged membranes (Fig. 6A/B). Temporin B caused a perturbation of the membrane 
characterized by bursts of current (fast events seen mostly as spikes) with a wide distribution of amplitudes, ultimately resulting in 
a destabilization of the membrane. Interestingly, temporin B activity started relatively soon after peptide addition, always causing 
an immediate rupture of the membrane (Fig. 7).  
Conductance induced by temporin B L1FK was also unaffected by membrane composition. Temporin B L1FK acted more slowly 
than temporin B (significantly so in DPhPG; p < 0.05) and induced a mixture of membrane activities, characterised by some 
channel-like events, with defined levels of amplitude, and irregular, fast events, similar to those induced by temporin B (Fig. 6C). 
In DPhPG, more pore-like events were visible, however the distribution of the opening and closing levels was broad and no single 
populations could be defined (Fig. 6D). Temporin B L1FK often broke DPhPE/DPhPG membranes, while it rarely broke DPhPG 
membranes (Fig. 7C/D), perhaps since conductance was achieved with a lower active concentration.  
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Membrane conductance induced by temporin B KKG6A was not detectable by electrophysiology unless a high concentration was 
reached. At these high concentrations, considerable destabilization of the membrane is observed with more numerous high 
amplitude events than observed for temporin B, particularly in DPhPG (Fig. 6E/F). Although conductance appears relatively soon 
after temporin B KKG6A addition, the membrane remains resilient and either does not break (Fig. 7C) or takes significantly longer 
(p < 0.05) to break than when challenged with much less temporin B (Fig. 7D). 
Discussion 
Time-resolved techniques distinguish mechanistic features between the three temporin B peptides. Here we investigated whether a 
combined biophysical approach is capable of discriminating the species specific antibacterial mechanisms of action between three 
analogues of temporin B. Although structures for the three peptides solved in anionic SDS were noticeably different, when applied 
to model membranes, little difference in conformation could be discerned in the steady state. To address this, we developed an 
approach using the Port-a-Patch® tool from Nanion Technologies (Munich, Germany) and correlated the findings obtained from 
patch-clamp analysis to the primary sequence and the biophysical behaviour of the peptides. Notably, these two time-resolved 
techniques were better able to distinguish the activity of the temporin B analogues. The time course of AMP action is increasingly 
recognized as an important parameter and it is notable that the time taken for membrane conductance to appear in model membranes 
is consistent with the time taken for the attack of AMPs on bacteria reported elsewhere.70,71 Although the pharmacodynamics of 
differing peptides will be variable, the latency associated with membrane activity of between 10 and 20 minutes for temporin B 
analogues is consistent with permeabilization of the E. coli cytoplasmic membrane68 and the induction of oxidative stress71 by LL-
37 after around 25 minutes, well after bacterial growth has halted. Although recent MD simulation studies of the behavior of 
multiple AMPs binding to membranes in systems of comparable size explore up to 800 ns,46 it is not possible to sample timescales 
required to understand this latency using all-atom molecular dynamics simulations. Instead, the MD simulations here describe the 
initial binding of the temporin B analogues to model bilayers - 100 ns is sufficient to sample a period in which a local minimum is 
attained46 - and succeed in discriminating different binding and insertion which can be directly related to the differences in primary 
sequence. 
The study of membrane active molecules, such as AMPs, with electrophysiology is complicated by their irregular activity when 
interacting with the bilayers. Indeed, only few AMPs apparently form regular single-channels when analysed with this technique,58-
60 while many show irregular membrane activity which is hard to define.58,71 Nevertheless, a rationale has been suggested in order 
to distinguish between the “barrel-stave”, “toroidal” pores or “carpet-like” mechanisms on the base of the current traces.55 Events 
showing a single-channel nature would characterise a pore, while an irregular current trace would be representative of a carpet 
mechanism. Moreover the different mechanisms could be distinguished on the basis of shorter or longer time constants of current 
activation and recovery, indicating a “barrel-stave” or a “toroidal” pore, respectively, and the irreversibility of the permeabilization 
process that would be the signature of a “carpet” like mechanism (detergent-like).57,61 This characterisation is based on the 
predominant models currently used to describe AMPs activity.1,7 However, more recent studies indicate many events at the bacterial 
plasma membranes are poorly described by these existing models and refinements or entirely new models are required to 
satisfactorily explain the behaviour of some AMPs; for instance the “snorkelling mechanism”,70,72 the “dynamic peptide-lipid 
supramolecular pore”72,75-77 or the “disordered toroidal pore”.44,52,78 Informed by molecular level information provided by MD 
simulations, the substantial changes in membrane activity amongst the three temporin B analogues are discussed below and indicate 
that relatively minor modifications of the primary sequence can cause substantial shifts between behaviours associated with each 
of the models described above. 
Temporin B is a hydrophobic AMP, prone to self-association. Temporin B and its two analogues are poorly studied, and little 
information is known about their mode of action. Hydrophobic AMPs such as temporin B have been proposed to go through an 
aggregation process and form fibrils as a step in the bactericidal process.79 As with amyloid peptides, this mechanism would form 
a cytotoxic intermediate which would cause the death of the cell (bacterial in this case) through poration of the plasma membrane. 
Evidence is indeed provided here for substantial aggregation of temporin B and its analogues but there is no evidence of any 
conformational shift, from α-helix to β-sheet, as characteristic of amyloid-like peptides as was predicted.79 A self-association of 
temporin B monomers through hydrophobic interactions was also reported on lipopolysaccharide;39,80 this was suggested to be the 
cause of the poor activity of this peptide against Gram-negative bacteria. Further, an increase in activity was observed for temporin 
B when used in combination with temporin L with the latter reported to inhibit the self-association. Presumably, temporin L can 
stabilise the monomer conformation of temporin B and/or cause structural changes in lipopolysaccharide when bound, which 
prevents temporin B aggregation. When in combination, the two peptides showed a higher potency in lipopolysaccharide 
disintegration.13,39,80 Primary sequence modification strategies that seek to reduce self-association of temporin B may therefore 
enhance its activity against Gram-negative bacteria. 
Modification of the temporin B primary sequence to create temporin B L1FK. Temporin B L1FK was computationally designed 
with a statistical model considering the cytotoxicity of the sequence, but also a close physicochemical pattern to the parent peptide.16 
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Temporin B L1FK behaves similarly to temporin B in inducing conductance albeit with a greater number of channel-like events 
and at somewhat lower concentrations and this correlates with the improved potency obtained against both E. coli NCTC 9001 and 
S. aureus Newman. We ascribe this improvement in membrane activity, and consequently in anti-bacterial potency, to increased 
insertion into the membrane associated with reduced self-association. This is achieved with greater hydrophobicity at the N-
terminus by substituting phenylalanine for leucine, the increased positive charge and the reduced conformational flexibility between 
residues six and eight. For both temporin B and temporin B L1FK, patch-clamp revealed no difference in activity according to 
membrane composition. In neither case could the observed activity be defined as regular single-channel formation, but rather a 
perturbation of the permeability of the membrane due to defects of the lipid bilayer that cause spikes of current. Unlike temporin 
B, temporin B L1FK, in addition to the spikes also caused some square-shaped events resembling channels or pores but 
characterized by disordered openings in which an uneven distribution of levels can be detected. Such conductance activity is well 
removed from that reported for “barrel-stave” or “toroidal” pores, as described previously for alamethicin, gramicidin A, cecropin 
B and dermicidin.58-60 Instead, the current traces obtained for both temporin B and temporin B L1FK are comparable to the ones 
obtained for gramicidin S,58 for which they suggest a mechanism similar to the so called “in-plane diffusion” model.81,82 In this 
model the peptides insert into the phospholipid bilayer disordering the packing and causing defects that can increase the membrane 
permeability. However, in this model the aggregation of peptides is considered minimal and unfavourable, while we observed 
considerable self-association for temporin B and, although reduced, also temporin B L1FK. The immediate membrane rupture 
observed for temporin B in all the electrophysiology measurements is consistent with the “carpet-like” mechanism, where peptides 
disintegrate the membrane following a detergent-like process.61,83 However, such behaviour was not observed for temporin B 
L1FK. Current traces similar to those obtained for temporin B L1FK, characterised by abrupt transient current spikes, were reported 
for poly-arginine peptides, known to act as cell-penetrating peptides (CPP).84 The deep and flat insertion, observed for this temporin 
B during the MD simulations, might suggest the ability of this peptide to better penetrate the bilayer and act inside the cell – activity 
not captured by techniques applied in the present study.  
Modification of the temporin B primary sequence to create temporin B KKG6A. Modification of temporin B through addition of 
two lysines at the N-terminus and replacement of a glycine with an alanine ensures that self-association of the resulting peptide, 
temporin B KKG6A, is substantially reduced. This is achieved though at cost of preventing insertion of the peptide, beyond the 
first two residues at the N-terminus, into either membrane and a very large increase in the amount of peptide required to obtain any 
conductance activity. This is a reminder that not only the net charge, but also its distribution along the sequence is important for 
AMPs activity.85,78 However, while this might explain the loss of activity against S. aureus, activity against E. coli was actually 
improved compared to the original temporin B peptide. Notably however, and in contrast to temporin B and temporin B L1FK that 
disorder the anionic phosphatidylglycerol component, temporin B KKG6A disorders the zwitterionic phosphatidylethanolamine 
component of membranes designed to mimic the plasma membrane of Gram-negative bacteria. This, together with a clear 
interaction with the headgroup region of the phospholipid bilayer observed in the MD simulations, suggests that the peptide is 
interacting with the membrane, but that the effect of this interaction does not readily induce channel conductance detectable through 
patch-clamp. The disorder observed in phosphatidylethanolamine lipids is related to the observation, in MD simulations, that 
temporin B KKG6A is particularly effective at clustering anionic lipids. This can be toxic to bacteria by disrupting membrane 
domains essential for specific interactions with other molecules86 and might not cause a leakage visible with technique as patch-
clamp. Adoption of this mechanism against E. coli is consistent with the loss of activity against Gram-positive S. aureus, the plasma 
membrane of which is mainly composed of negatively charged lipids.65-69 Whether this or other mechanisms more accurately 
describe the behaviour and anti-bacterial activity of temporin B KKG6A, it is clear that, following the optimization process, its 
mechanism of action differs substantially from the native temporin B peptide.  
Conclusion  
Since cecropin, the first AMP, was isolated from the hemolymph of the silk moth Hyalophora cecropia in 1981,87 AMPs have been 
studied as a new interesting class of molecules for the development of new antibiotics. The attraction of these short, cationic 
peptides is related to their ability to defeat infections from many different pathogens (bacteria, fungi, viruses) and, in particular, 
the low rate of bacterial resistance onset.1-3,6 Despite the efforts made to characterize different AMPs from different sources, there 
is still a lack of understanding of their specific modes of action and variation thereof due to sequence modifications.1 The activity 
of temporin B is likely improved in vivo through its synergistic interaction with temporin L which acts to prevent self-association. 
Both sequence modification strategies described here also act to reduce self-association of the AMP in the target membrane but 
lead to fundamentally different behaviour which was revealed by a combination of MD simulations and patch-clamp conductance 
recordings but not by e.g. circular dichroism. Therefore, in characterising the membrane interaction of temporin B and its analogues, 
the present study shows that even minor alterations to AMP primary sequences may cause drastic changes in the mechanism of 
interaction with bacterial plasma membranes which in turn affect antibacterial potency and selectivity. Future attempts to enhance 
the potency of designed or naturally occurring AMP sequences will be aided by as sophisticated as possible understanding of the 
crucial peptide-peptide and peptide-membrane interactions and their outcomes.  
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Tables 
 
Table 1. Peptides sequences, biophysical characteristics and concentration of peptide necessary to start membrane activity in 
electrophysiology experiments. All peptides were amidated at the C-terminus. Hydrophobicity (H) and hydrophobic moment (µH) 
were calculated using HeliQuest.88 
Peptide Sequence Length Charge H H 
Peptide concentration 
(µM) 
DPhPE/DPhPG DPhPG 
Temporin B LLPIVGNLLK SLL 13 +2 0.947 0.601 25.34 35 
Temporin B L1FK FLPIVGLLKS LLK 13 +3 0.924 0.548 11.32 4.94 
Temporin B KKG6A KKLLPIVANL LKSLL 15 +4 0.709 0.600 200 100 
 
Table 2. Antimicrobial activity. MS – methicillin sensitive; EMR – epidemic methicillin resistant; VS – vancomycin sensitive; 
VR – vancomycin resistant; MH – Müller-Hinton broth; TSB – tryptic soy broth. Data in bold indicates a four-fold or more increase 
in MIC or a MIC becoming undetectable according to change in media used. 
  Peptide concentration (µg/ml) 
  Temporin B Temporin B KKG6A Temporin B L1FK 
  MHB TSB MHB TSB MHB TSB 
G
ra
m
-n
eg
at
iv
e 
Klebsiella pneumoniae NCTC 13368 128 >128 128 >128 32 128 
Klebsiella pneumoniae M6 128 >128 128 >128 32 64 
Acinetobacter baumanii AYE 32 64 32 64 8 8 
Acinetobacter baumanii ATCC 17978 64 128 32 64 8 16 
Pseudomonas aeruginosa PAO1 >128 >128 >128 128 128 128 
Pseudomonas aeruginosa NCTC 13437 128 >128 >128 >128 128 >128 
Escherichia coli NCTC 12923 64 128 16 64 8 64 
   
G
ra
m
-p
o
si
ti
v
e 
MS Staphylococcus aureus NCTC 6571 16 16 128 >128 4 8 
EMR Staphylococcus aureus-15 NCTC 13616 16 64 >128 >128 16 16 
EMR Staphylococcus aureus-16 NCTC 13277 32 32 >128 >128 16 16 
VS Enterococcus faecalis NCTC 775 64 128 >128 >128 32 64 
VR Enterococcus faecalis NCTC 12201 64 >128 >128 >128 64 128 
   
 Candida albicans NCPF 3179 32 128 64 128 16 64 
 
 
